This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Guangdong Cell Biotechnology Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Fei Peng: Innovator in Stem Cell-Derived Exosome Applications
Introduction
Fei Peng is a notable inventor based in Dongguan, China. He has made significant contributions to the field of biotechnology, particularly in the application of transgenic stem cell-derived exosomes. His innovative work has the potential to revolutionize the development of medicaments and cosmetics.
Latest Patents
Fei Peng holds a patent for the "Application of transgenic stem cell-derived exosome in preparing medicament or whitening cosmetic." This patent describes a method where miR-27b-3p is transfected into epidermal stem cells to harvest exosomes. Experimental results indicate that these exosomes can inhibit the expression of PIK3R3 protein in melanocytes, as well as their proliferation and migration. Safety experiments further validate the exosome's safety, suggesting promising applications in both medicinal and cosmetic fields.
Career Highlights
Fei Peng is associated with Guangdong Cell Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and the application of cutting-edge biotechnology.
Collaborations
Fei Peng collaborates with talented individuals such as Xinyi Shi and Taihua Wang, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Fei Peng's contributions to the field of biotechnology, particularly through his patent on stem cell-derived exosomes, highlight his role as a leading inventor. His work not only showcases the potential for new medicaments and cosmetics but also emphasizes the importance of innovation in scientific research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile